Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection
about
Thymosin beta 4 is dispensable for murine cardiac development and functionRecent Stem Cell Advances: Cord Blood and Induced Pluripotent Stem Cell for Cardiac Regeneration- a ReviewGene and cell therapies for the failing heart to prevent sudden arrhythmic deathHASF is a stem cell paracrine factor that activates PKC epsilon mediated cytoprotectionThymosin beta4 inhibits TNF-alpha-induced NF-kappaB activation, IL-8 expression, and the sensitizing effects by its partners PINCH-1 and ILKIn vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytesThymosin β4 Improves Differentiation and Vascularization of EHTs.Stem cell therapy: pieces of the puzzle.Serum thymosin beta4 levels in patients with hepatitis B virus-related liver failureExogenous thymosin beta4 prevents apoptosis in human intervertebral annulus cells in vitro.Thymosin beta4 improves functional neurological outcome in a rat model of embolic stroke.Cell-responsive hydrogel for encapsulation of vascular cells.Thymosin-β4 prevents cardiac rupture and improves cardiac function in mice with myocardial infarction.Paracrine mechanisms of stem cell reparative and regenerative actions in the heartRegulation of PTEN/Akt pathway enhances cardiomyogenesis and attenuates adverse left ventricular remodeling following thymosin β4 Overexpressing embryonic stem cell transplantation in the infarcted heart.Stem Cell Therapy in Acute Myocardial Infarction: A Pot of Gold or Pandora's Box.Thymosin beta4: a candidate for treatment of stroke?Thymosin Beta 4 protects mice from monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy.Thymosin β4 overexpression regulates neuron production and spatial distribution in the developing avian optic tectum.Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models.The birth of 'regenerative pharmacology': a clinical perspective.Pluripotent stem cells for cardiac regeneration: overview of recent advances & emerging trends.Thymosin β4 is not required for embryonic viability or vascular development.A Tobacco-Derived Thymosin β4 Concatemer Promotes Cell Proliferation and Wound Healing in MiceCardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease.Heart failure therapy mediated by the trophic activities of bone marrow mesenchymal stem cells: a noninvasive therapeutic regimenImage-guided therapies for myocardial repair: concepts and practical implementation.Neurological functional recovery after thymosin beta4 treatment in mice with experimental auto encephalomyelitis.Coronary vessel development and insight towards neovascular therapy.Stem cell therapy for cardiac repair: benefits and barriers.Regenerative therapies in electrophysiology and pacing: introducing the next steps.Adjuvant early and late cardioprotective therapy: access to the heart.Thymosin β4 and cardiac regeneration: are we missing a beat?Thymosin β4 and cardiac protection: implication in inflammation and fibrosis.Roles and mechanisms of β-thymosins in cell migration and cancer metastasis: an update.Thymosin β4: multiple functions in protection, repair and regeneration of the mammalian heart.Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence.Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue.Thymosin beta 4 ophthalmic solution for dry eye: a randomized, placebo-controlled, Phase II clinical trial conducted using the controlled adverse environment (CAE™) model.Cellular mechanisms underlying cardiac engraftment of stem cells.
P2860
Q24632556-4B773801-A90C-419A-9594-AA351EC67ABBQ26739985-C65E75B4-A82A-4AC9-9E83-5604092DFE3AQ26865425-05FE5C99-3A85-47D2-A7FE-FC9B97EF7469Q28302576-55B18487-21A3-4152-A460-5555E35D9B3FQ28910436-F4BFE2EE-8A59-4E79-8068-5B0B75F1CE40Q29620599-BE42C9C4-CDE3-4268-857A-10500A9D9E8CQ30836792-8FDBDB83-5082-489D-BF15-82975980B899Q33348580-26008937-22E5-4375-AA4D-355F5298CEA5Q33629461-53951948-595F-4E75-ABE6-8A3C062DBCBEQ33916448-05C61064-B7AF-419B-BA35-B59B4E9C19D7Q34007803-6B4C67D3-3EAF-4312-BA11-E0BA83F173E5Q34149528-B5E3D1F8-7D0A-476F-BC9E-314E31C846E9Q34296720-3E0599CC-26EF-4F9C-824A-99BEA18FBDE4Q34494230-02A15BE2-D26C-4C06-909E-70D359F8570BQ35005781-E730BB68-D4CA-42A1-8E5C-BAEB03FFE095Q35125820-32C5E7EB-58D5-423C-BDAD-8485A091F882Q35135176-90C88845-B316-4895-A0D5-2BA38C120008Q35439583-77A55803-BCC3-47AF-A2AF-0F2B47314323Q36220357-A11B2E2C-AB5E-4AE1-8C1C-6A619EE4166CQ36744812-F522FE44-F74F-47DD-8B8B-406B2B8ED45CQ36836344-DCB4CDA3-F09C-4191-BEE8-8E3C3BA0D53CQ36855438-7DCAF261-FA51-4CFB-8E93-18E8BE77989DQ37015213-153692A1-425D-4127-8D57-AC555993050DQ37132308-76C5F8C9-E9A3-4DAE-AD18-EA948A776173Q37253735-3013BE82-E9E1-450D-9665-8D71268F0907Q37276182-77327E93-22C7-44C9-81AC-B4E4785A5FBEQ37383576-21CF8C82-9351-4A15-8E99-5C764AD3DBCCQ37441914-3C888819-83E2-41B9-ACF3-BE099B7C3318Q37534988-8637044F-E668-450B-AA80-4DC60A9371B3Q37544884-AF0D4A0D-DFC9-46BB-B9CF-19164DDC4B85Q37821376-18AE27AB-A757-460A-812F-30D50F924F3EQ37982681-8D12427D-D631-4872-B1CB-3D04CF452234Q38013063-F668E5A4-312A-4626-82E9-2DBCF86BCA57Q38050454-09FA574E-BE2D-4CFD-82D8-FF2FFA65F905Q38074194-F09C88A8-99A0-4470-A331-80984F4D450DQ38533285-E4DA1290-FD5B-4321-9E94-56C86173C69CQ38869952-664612EB-05AA-42CD-B244-8D66242FA6BFQ38919999-F1F8AC28-650C-4B47-B47A-3C32C34B47C9Q39188067-F081B113-E4AD-45DB-ABA1-8DBF517F7CC8Q39410733-41F12A2F-0F05-4ACC-AC92-C6D6BC293611
P2860
Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Thymosin beta4 is an essential ...... cell-mediated cardioprotection
@en
Thymosin beta4 is an essential ...... ell-mediated cardioprotection.
@nl
type
label
Thymosin beta4 is an essential ...... cell-mediated cardioprotection
@en
Thymosin beta4 is an essential ...... ell-mediated cardioprotection.
@nl
prefLabel
Thymosin beta4 is an essential ...... cell-mediated cardioprotection
@en
Thymosin beta4 is an essential ...... ell-mediated cardioprotection.
@nl
P2093
P2860
P1433
P1476
Thymosin beta4 is an essential ...... cell-mediated cardioprotection
@en
P2093
Antonis K Hatzopoulos
Chiraz El-Aouni
Christian Kupatt
Christine Spitzweg
Ewald Hannappel
Franz-Josef Gildehaus
Ildiko Bock-Marquette
J Michael DiMaio
Jan Horstkotte
Michael Willhauck
P2860
P304
P356
10.1161/CIRCULATIONAHA.107.758904
P407
P577
2008-04-21T00:00:00Z